Sign Up to like & get
recommendations!
0
Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1714592
Abstract: ABSTRACT Introduction Lefamulin is a novel antibiotic that belongs to the pleuromutilin class with excellent activity against all microorganisms, including atypical pathogens, that cause community-acquired pneumonia (CAP). Areas covered This article reviews the spectrum of…
read more here.
Keywords:
lefamulin;
treatment;
overview lefamulin;
community acquired ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00355-22
Abstract: Lefamulin, a semisynthetic pleuromutilin antibiotic approved in the United States, Canada, and Europe for intravenous and oral treatment of community-acquired bacterial pneumonia, is highly active in vitro against bacterial pathogens that cause sexually transmitted infections…
read more here.
Keywords:
urogenital tract;
lefamulin;
14c lefamulin;
male female ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028020932521
Abstract: Objective: To review the pharmacology, microbiology, efficacy, and safety of lefamulin. Data Sources: A literature search was performed using PubMed and Google Scholar (2010 to end-April 2020) with the search terms BC-3781 and lefamulin. Other…
read more here.
Keywords:
lefamulin;
first systemic;
lefamulin first;
pleuromutilin antibiotic ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2020.578824
Abstract: Purpose Lefamulin is a novel antibiotic approved by the U.S. Food and Drug Administration in 2019 for the treatment of community-acquired bacterial pneumonia (CABP). In this study we evaluated the in vitro antimicrobial activity of…
read more here.
Keywords:
lefamulin;
mic50;
respiratory pathogens;
activity lefamulin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1035841
Abstract: The emergence and spread of antimicrobial resistance in Neisseria gonorrhoeae is seriously threatening the treatment and control of gonorrhea globally. Novel treatment options are essential, coupled with appropriate methods to pharmacodynamically examine the efficacy and…
read more here.
Keywords:
neisseria gonorrhoeae;
gonorrhea;
lefamulin;
resistance ... See more keywords